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ABSTRACT
Type 2 diabetes mellitus (T2DM) is a chronic disease that oen
results in multiple complications. Risk prediction and proling
of T2DM complications is critical for healthcare professionals to
design personalized treatment plans for patients in diabetes care for
improved outcomes. In this paper, we study the risk of developing
complications aer the initial T2DM diagnosis from longitudinal
patient records. We propose a novel multi-task learning approach
to simultaneously model multiple complications where each task
corresponds to the risk modeling of one complication. Specically,
the proposed method strategically captures the relationships (1)
between the risks of multiple T2DM complications, (2) between
the dierent risk factors, and (3) between the risk factor selection
paerns. e method uses coecient shrinkage to identify an infor-
mative subset of risk factors from high-dimensional data, and uses
a hierarchical Bayesian framework to allow domain knowledge to
be incorporated as priors. e proposed method is favorable for
healthcare applications because in additional to improved predic-
tion performance, relationships among the dierent risks and risk
factors are also identied. Extensive experimental results on a large
electronic medical claims database show that the proposed method
outperforms state-of-the-art models by a signicant margin. Fur-
thermore, we show that the risk associations learned and the risk
factors identied lead to meaningful clinical insights.
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1 INTRODUCTION
Type 2 diabetes mellitus (T2DM) is a chronic disease that aects
nearly half a billion people around the globe [33]. T2DM is char-
acterized by hyperglycemia— abnormally elevated blood glucose
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(blood sugar) levels, and is almost always associated with a number
of complications [15]. Over time, the chronic elevation of blood
glucose levels caused by T2DM leads to blood vessel damage which
in turn leads to associated complications, including kidney fail-
ure, blindness, stroke, heart aack, and in severe cases even death.
Meanwhile, the cost of diabetes care has been increasing over the
past decades and the annual cost is a staggering [9, 13]. T2DM
management requires continuous medical care with multifactorial
risk-reduction strategies beyond glycemic control [2]. Risk prol-
ing of T2DM complications is critical for healthcare professionals
to appropriately adapt personalized treatment plans for patients in
diabetes care, improving care quality and reducing cost.
e recent abundance of the electronic health records (EHRs)
and electronic medical claims data has provided an unprecedented
opportunity to apply predictive analytics to improve T2DM man-
agement. In this paper, we study the risk proling of T2DM com-
plications from longitudinal patient records: what is the probability
that a patient will develop complications within a time window af-
ter the initial T2DM diagnosis? In the literature, EHRs and claims
data have been leveraged for a wide range of healthcare applica-
tions [10–12, 17, 18, 21, 22, 25, 28, 30, 31]. However, there are unique
diculties that arise when performing data-driven risk prediction
and proling of T2DM complications from patient medical records:
• e rst challenge stems from the need to eectively capture
correlations between multiple T2DM complications. Con-
sidering that the dierent complications are manifestations
of a common underlying condition–hyperglycemia, model-
ing complications as independent of one another leads to
suboptimal models.
• Patient medical record data contain rich information about
relationships among medical concepts and risk factors, perti-
nent to T2DM. However, developing statistical methods that
can eectively exploit this information is challenging.
• Further, when using patient medical record data for risk pre-
diction and proling, each patient is typically represented by
very high-dimensional data while only a small subset of the
predictors are actually relevant. It is essential to be able to
identify the subset of predictors that are useful for predictive
analysis to facilitate model transparency and interpretability.
• Finally, it is desirable for the model to have the ability to
leverage T2DM domain knowledge. Such clinical domain
knowledge is oen available or partially available, and in-
corporating it into the analysis can lead to more accurate
inferences.
In this paper, we address these challenges by developing meth-
ods for simultaneously modeling multiple complications for risk
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proling in diabetes care. We begin by formulating T2DM compli-
cation risk prediction as a Multi-Task learning (MTL) [6] problem
with each complication corresponding to one task. MTL jointly
learns multiple tasks using a shared representation so that knowl-
edge obtained from one task can help the other tasks. We then
develop extensions that in addition to capturing task relationships
driven by the underlying disease also model dependencies between
information-rich features (risk factors). Further, assuming that sim-
ilar T2DM complications have similar contributed risk factors, we
endow our models with the ability to perform correlated shrinkage
through a novel correlated Horseshoe distribution. is allows
us to identify subsets of risk factors for dierent complications
while accounting for associations between complications. We call
the proposed method Task RElationship and Feature relationship
Learning with correlated Shrinkage (TREFLES). We formulate TRE-
FLES in a hierarchical Bayesian framework, allowing us to easily
capture domain knowledge through carefully chosen priors.
Finally, we assess our proposed innovations through extensive
experiments on patient level data extracted from a large electronic
medical claims database. e results show that the proposed ap-
proach consistently outperforms previous models by a signicant
margin and demonstrate the eectiveness of the simultaneous mod-
eling framework over modeling each complication independently.
Furthermore, we show that the risk associations learned and the
risk factors identied lead to meaningful clinical insights.
In summary, our key contributions are as follows:
• We provide a systematic study on risk proling by simultane-
ously modeling of multiple complications in chronic disease
care using T2DM as a case study.
• We design a novel model, TREFLES, that jointly captures rela-
tionships between risks, risk factors, and risk factor selection
learned from the data with the ability to incorporate domain
knowledge as priors.
• We demonstrate the eectiveness of TREFLES in both predic-
tive capability and clinical interpretability via a comprehen-
sive study of T2DM complications using a large electronic
medical claims database.
e proposed method is favorable for healthcare applications be-
yond diabetes care. It provides a powerful tool for not only im-
proving predictive performance, but also for recovering clinically
meaningful insights about relationships among dierent risks and
risk factors.
2 SIMULTANEOUS MODELING OF MULTIPLE
COMPLICATIONS FOR RISK PROFILING
In this section, we rst formulate the problem of diabetes compli-
cations risk proling, and then introduce the proposed approach
to simultaneously model multiple complications, addressing the
aforementioned challenges.
2.1 Diabetes Complications Risk Proling
e goal is to build an eective approach to predict the risk of a
patient developing complication(s) within a follow-up window ∆t
aer the initial T2DM diagnosis. Specically, as shown in Figure
1, for each patient i ∈ {1, . . . ,N } we observe a set of M features
Table 1: Mathematical Notations
Symbol Description
N ,M,K number of subjects, features, and complications
i, j,k index of subjects, features, and complications
cki ∈ {0, 1} event of complication k for patient i where 1indicates an observed event and 0 otherwise
yki probability (risk) of patient i for complication k
xi ∈ RM vector of features for patient i
wk ∈ RM vector of coecients for complication k
W ∈ RM×K W = [w1, · · · ,wK ] is the matrix of coecients
wj ∈ RK wj is the jth row of coecient complication W
Ω ∈ RK×K matrix of relatedness between complications
Ω0 ∈ RK×K matrix of prior knowledge about risk association
z,Gz index and the zth group of features
Σz ∈ RGz×Gz correlation matrix between features in group Gz
(risk factors), denoted as xi = [xi1,xi2, . . . ,xiM ]>, for an obser-
vation window up until the patient was initially diagnosed with
T2DM. Let there be K complications in consideration indexed by
k ∈ {1, . . . ,K}. We use cki ∈ {0, 1} to represent the onset event of
patient i developing complication k in the follow-up window ∆t
and use yki to represent the event probability (risk). For each task
k we observe a set of complicationsDk = {xi , cki }i ∈Nk , whereNk
are the patients observed in complication k . e set of all observed
complication events are denoted as D = {Dk }Kk=1. Given D, we
aim to build a predictive model yki = Pr(cki |Θ, xi ), where Θ are
the model parameters, to predict the risk that patient i will de-
velop complication k during follow-up. Table 1 summarizes useful
notation used in the remainder of the paper.
2.2 Learning Associations between Multiple
Complications
Given the features (risk factors) xi = [xi1,xi2, . . . ,xiM ]> observed
up until the initial T2DM diagnosis for patient i , we model the risk
of patient i developing complication k in the follow-up window ∆t
as:
yki = Pr(cki |Θ, xi ) = σ (w>k xi ) (1)
where wk is the coecient vector for complication k , and σ (t) is a
logistic function σ (t) = 11+e−t . en the event onset can be modeled
as a draw from a Bernoulli distribution cki ∼ Bernoulli(σ (w>k xi )).
To capture and leverage the association between the risks of the
dierent T2DM complications, we formulate the complication risk
prediction problem as a multi-task learning problem. As shown in
Figure 1, we group the predictions of multiple complications in con-
sideration (e.g., retinopathy, neuropathy and vascular disease) into
dierent learning tasks. Each task models only one complication
risk via Equation (1). Next, we apply multi-task learning to capture
the association between dierent complications.
2.3 Learning Multi-task and Feature
Relationships with Correlated Shrinkage
We aim to capture three types of dependencies in our framework.
First, the complication tasks are related since they all stem from a
common underlying condition–hyperglycemia. Second, there are
associations between the features since they are derived from and
represent the health status of the same set of real patients. ird,
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(a) Multi-task learning formulation.
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Figure 1: Proposed framework for simultaneous modeling of multiple T2DM complications. (a) Multi-task learning formu-
lation: the predictions of multiple complications in consideration (e.g., retinopathy, neuropathy and vascular disease) are
grouped into dierent tasks where each task models only one complication. Multi-task learning (MTL) is applied to capture
the association between the dierent complications. Features are derived from patients’ medical records up to the time of
the initial T2DM diagnosis. Outcome is evaluated in the follow-up window. To simplify the illustration, only positive cases
are shown. (b) e correlations between complication risks are revealed in the structure of the coecient matrix W, which
captures both the relationships between T2DM complication risk proling tasks and the correlation between the features.
similar T2DM complications have similar contributing risk factors
that lead to the development of those complications.
2.3.1 Modeling Task and Feature Associations.
Let W = [w1,w2, . . . ,wK ] ∈ RM×K denote the matrix of coe-
cients of all K complications in consideration. To explore the latent
association between the risks of T2DM complications, we impose
explicit structure on the coecient matrix W. Specically, we as-
sume that the coecient matrix W follows a Matrix Variate Normal
(MVN) distribution:
W ∼ MVN(0,Σ,Ω). (2)
e the rst term 0 is a M × K matrix of zeros representing the
mean of W. e second term Σ is a M × M symmetric positive
denite matrix representing the row-wise covariances of W, i.e.
the correlations between the features. e third term Ω is a K × K
symmetric positive denite matrix representing the column-wise
covariance of W, i.e. the correlations between the tasks.
Equation (2) captures both the relationships between tasks through
Ω and correlations among features through Σ. As a result, this for-
mulation is a generalization [38] of the two most widely used MTL
strategies: the task relation learning approaches [36, 37] and the
feature relationship learning approaches [3, 4]. When Σ is diagonal,
we recover task relationship learning, and by seing Ω to a diagonal
matrix, we recover feature relationship learning.
In healthcare, features can be very ne-grained and domain
knowledge is oen available to group similar features into higher
level representations. In this paper, we leverage this knowledge
and group the diagnosis features in the patient medical records
according to the ontologies of the International Classication of
Diseases (ICD) [24]. As a result, we group the features {x j }Mj=1 into
Z groups {Gz }Zz=1, where Gz has Gz features with
∑
z Gz = M .
Let wj = [w j1,w j2, . . . ,w jK ] ∈ RK be the j row of coecient
complication matrix W, then wj is the jth coecient across the K
tasks. As shown in Figure 1b, we group coecient matrix W into
Z blocks where each Wz ∈ RGz×K is a matrix block where feature
j belongs to group Gz , namely, Wz = {wj }j ∈Gz . We assume Wz
follows a Matrix Variate Normal (MVN) distribution:
Wz ∼ MVN(0,Σz ,Ω) (3)
where 0 is the mean, Σz is the correlations between features, and Ω
is the correlations between tasks. e zero mean indicates a-priori
the features are assumed to have no eect. As a result, Equation (3)
captures both the relationships between T2DM complications and
the relationships between features. en we have,
Pr(Wz |0,Σz ,Ω) =
exp
(
− 12 tr
[
Ω−1W>z Σz−1Wz
] )
(2pi )KGz/2 |Σz |K/2 |Ω|Gz/2
. (4)
2.3.2 Correlated Shrinkage. EHR data is usually high-dimensional
with a large numbers of potentially relevant features. We are in-
terested in identifying an informative subset of coecients, which
reect the contributing risk factors responsible for the develop-
ment of a specic complication, by shrinking irrelevant coecients
towards zero. Sparsity-promoting priors are widely used in this
context. Perhaps, the most popular example is the Laplacian prior
which gives rise to the Lasso [29] `1 regularizer. However, such
a prior provides uniform shrinkage — it shrinks values close and
far from zero alike. e Horseshoe prior [7, 8] provides an arac-
tive alternative. It maintains an innitely tall spike at zero, while
exhibiting Cauchy-like heavy tails. As a consequence, it shrinks
small values to zero more strongly than the Laplace prior, while its
heavy tails allow some coecients to escape completely un-shrunk.
is property allows the Horseshoe prior to be more robust to large
signals while providing strong shrinkage towards zero to noise. We
can place a Horseshoe prior on w jk to promote sparsity on the jth
coecient of task k by seing,
w jk |λjk ,τ ∼ N(0, λ2jkτ 2), λjk ∼ C+(0, 1),τ ∼ C+(0, 1) (5)
where C+(0, 1) is a half-Cauchy distribution, λjk is called the local
shrinkage parameter, and τ is the global shrinkage parameter.
However, the vanilla Horseshoe prior fails to capture correlations
among tasks. Recall that in our MTL seing, we assume that similar
Conf’18, July 2018, City, State USA B. Liu et al.
T2DM complications (tasks) should have similar contributing fea-
tures. Note that wj = [w j1,w j2, . . . ,w jk . . . ,w jK ] ∈ RK is the jth
coecient across the K tasks. Ideally, pairs of w jk ,k ∈ {1, . . . ,K}
would have more similar shrinkage if their tasks (k) are positively
correlated.
To do so, we introduce a novel correlated Horseshoe prior. We
construct the correlated Horseshoe prior by employing a Gaussian
copula [26] to couple the local shrinkage parameters λjk together
via the task correlations reected in Ω, while forcing the marginals
of λjk to retain their half-Cauchy distributions.
Let uj = [uj1,uj2, . . . ,ujK ] ∈ RK be a K-dimensional vector
that follows a multivariate normal distribution
[uj1,uj2, . . . ,ujk . . . ,ujK ] ∼ MN(0,Ω), (6)
Observe that uj preserves the correlations between tasks through Ω
and ujk ∼ N(0,Ωkk ). Next, we need to ensure that λjk follows the
half-Cauchy distribution. We use inverse transform sampling [14]
to guarantee half-Cauchy marginals. Inverse transform sampling is
based on the result that given a uniform random variablea ∼ U (0, 1),
we can generate another random variable b with a cumulative
distribution function (cdf) F, by seing b = F−1(a), as long as F
is invertible. Now, if b ∼ C+(0, 1), then F(b) = 2pi tan−1(b) and
since, Φ(ujk ) ∼ U (0, 1), where Φ(ujk ) is the cdf of ujk , F−1(Φ(ujk ))
follows a half-Cauchy distribution. e correlated Horseshoe is
thus completely specied as,
uj ∼ MN(0,Ω), Φ(ujk ) =
1
2
[
1 + erf
(
ujk√
2Ωkk
)]
,
λjk = F−1(Φ(ujk )) = tan
(
piΦ(ujk )
2
)
∀k ∈ {1, . . . ,K},
w jk |λjk ,τ ∼ N(0, λ2jkτ 2), τ ∼ C+(0, 1).
(7)
We emphasize that λjk s are correlated via the latent variables uj ,
allowing us to preserve task correlations. At the same time their
marginal half-Cauchy behavior retains the desirable properties of
the Horseshoe distribution.
2.3.3 Capturing Domain Knowledge. In order to utilize available
domain knowledge, we impose an Inverse-Wishart prior distribu-
tion on Ω
Ω ∼ IW(δΩ0,ν ). (8)
e Inverse-Wishart distribution is a conjugate prior for the multi-
variate Gaussian distribution. Ω0 is a known symmetric positive
denite matrix that contains all prior knowledge about the risk
associations. δ and ν are two tuning parameters. When domain
knowledge on risk associations is available, the prior distribution
can leverage the information and help improve the estimation of Ω.
When domain knowledge about risk associations is not available,
we can set Ω0 to be the identify matrix I.
2.4 Prediction
Note that in Equation (7), we have w jk |λjk ,τ ∼ N(0, λ2jkτ 2) and
λjk is a function of ujk , which is sampled from MN(0,Ω). An
equivalent non-centered re-parameterization is given by τλjk ·w jk ,
wherew jk ∼ N(0, 1). Here, we use this equivalent parameterization
for computational convenience. Let Λ ∈ RM×K be a matrix with
element λjk , then we can reparameterize the matrix of coecients
as β = τΛ◦W, where ◦ represents a pointwise (Hadamard) product
between Λ and W. Finally, we model the risk of complication k for
patient i as, yki | βk , xi = σ (β>k xi ).
3 PARAMETER ESTIMATION
Let Θ =
{{Wz ,Σz }Zz=1,Ω,U,τ } denote all parameters to be esti-
mated, and Φ = {Ω0,δ ,ν } denote all hyperparameters. For each
taskk we observe a set of complication eventsDk = {〈xi , cki 〉}i ∈Nk ,
whereNk represents the patients observed for complication k . e
observed complication events are denoted asD = {Dk }Kk=1. Given{D,Φ} the posterior distribution,
Pr(Θ|D,Φ)
∝ Pr(τ )Pr(Ω)
K∏
k=1
Nk∏
i=1
Pr(cki |βk , xi )
Z∏
z=1
Pr(Wz )
M∏
j=1
Pr(uj )
∝ 2
pi (1 + τ 2) |Ω|
− ν+K+12 exp
(
−δ2 tr(Ω0Ω
−1)
) K∏
k=1
Nk∏
i=1
Pr(cki |βk , xi )
×
Z∏
z=1
exp
(
− 12 tr
[
Ω−1W>z Σ−1z Wz
] )
(2pi )KGz/2 |Σz |K/2 |Ω|Gz/2
M∏
j=1
exp
(
− 12 ujΩ−1(uj )>
)
(2pi )K/2 |Ω|1/2 .
We estimate the parameters via maximizing the log posterior `(Θ) =
log Pr(Θ|D,Φ).
Objective Function. We rewrite the negative log-posterior `(Θ)
to obtain the following objective function O(Θ) to minimize:
O =
K∑
k=1
Nk∑
i=1
{
− cki logσ (β>k xi ) − (1 − cki ) log(1 − σ (β>k xi ))
}
+
1
2
Z∑
z=1
{
tr
[
Ω−1W>z Σ−1z Wz
] }
+
2M + K + ν + 1
2 log |Ω|
+
δ
2 tr(Ω0Ω
−1) + K2
Z∑
z=1
log |Σz | + 12
M∑
j=1
ujΩ−1(uj )> + 2 log(1 + τ 2)
s.t. Ω  0,Σz  0.
where X  0 means that the matrix X is positive semidenite.
Solving the above optimization problem is non-trivial. e op-
timization problem is not convex since log |Ω| and log |Σz | are
concave functions. erefore we adopt an iterative algorithm to
solve the problem. Within each iteration, the blocks Wz , Σz , Ω, U,
and τ are updated alternatively.
Update Wz given others: With other parameters xed, objective
function w.r.t Wz becomes
arg min
{Wz }Zz=1
K∑
k=1
Nk∑
i=1
{
− cki logσ (β>k xi ) − (1 − cki ) log(1 − σ (β>k xi ))
}
+
Z∑
z=1
{
1
2 tr
[
Ω−1W>z Σ−1z Wz
] }
.
is is a convex optimization problem with respect to Wz . We
use stochastic gradient descent method to update the {Wz }Zz=1.
e main process involves randomly scanning training instances
and iteratively updating parameters. In each iteration, we ran-
domly sample an instance 〈xi , cki 〉, and we minimize O(Θ) using
the update rule for Θ = Θ − ϵ · ∂O(Θ)∂Θ , where ϵ is a learning rate.
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Note that wk = [wG1 ,wG2 , . . . ,wGZ ]> and Wz = {wj }j ∈Gz . Let
wGzk = [w jk ,w jk , · · · ,w jk ]>, j ∈ Gz be the k column of Wz , then
wGzk corresponds to the coecients of features in group Gz in task
k . Given an instance 〈xi , cki 〉, the gradient with respect to wGzk is
∂O
∂wGzk
= −
(
cki − σ (β>k xi )
) ∂β>k xi
∂xGzi
+
[
Σ−1z WzΩ−1
]Gz
k (9)
where xGzi is the features in group z, and [X]k means the k-th
column of matrix X. So we have ∂β
>
k xi
∂xGzi
= τλGzk ◦ x
Gz
i .
UpdateU given others: With other parameters xed, the objective
function w.r.t U becomes
arg min
U
K∑
k=1
Nk∑
i=1
{
− cki logσ (β>k xi ) − (1 − cki ) log(1 − σ (β>k xi ))
}
+
1
2
M∑
j=1
ujΩ−1(uj )>
To apply SGD, we optimize columns uk instead of rows uj . Note
than
∑M
j=1 u
jΩ−1(uj )> = tr(UΩ−1U>). Given an instance 〈xi , cki 〉,
the gradient with respect to uk is
∂O
∂uk
= −
(
cki − σ (β>k xi )
) ∂β>k xi
∂uk
+
[
UΩ−1
]
k
(10)
Note that βjk = τλjkw jk with λjk = tan
(
piΦ(ujk )
2
)
,Φ(ujk ) =
1
2
[
1 + erf
(
ujk√
2Ωkk
)]
. en ∂β
>
k xi
∂uk
= τ
∂f (uk )
∂uk
◦xi , where ∂f (uk )∂uk

jk
=
pi
2 sec
2
(
piΦ(ujk )
2
)
1√
2piΩ2kk
exp
(
− u
2
jk
2Ω2kk
)
.
Update τ given others: With other parameters xed, the objective
function w.r.t τ becomes
arg min
τ
K∑
k=1
Nk∑
i=1
{
− cki logσ (β>k xi ) − (1 − cki ) log(1 − σ (β>k xi ))
}
+ 2 log(1 + τ 2)
e gradients with respect to τ are given by
∂O
τ
= −
K∑
k=1
Nk∑
i=1
(
cki − σ (β>k xi )
)
λ>k xi +
4τ
1 + τ 2
(11)
where λk is the k-column of Λ. is allows τ to be updated using
gradient decent.
Update Ω given others: With other parameters xed, the objec-
tive function w.r.t Ω becomes
arg min
Ω
Z∑
z=1
{
1
2 tr
[
Ω−1W>z Σ−1z Wz
] }
+
δ
2 tr(Ω0Ω
−1) + ξ2 log |Ω|,
where ξ = 2M + K + ν + 1. e last term log |Ω| can be seen
as a penalty on the complexity of Ω, and can be replaced with
the constraint tr(Ω) = 1 [36]. en above Equation (3) can be
reformulated as:
arg min
Ω
Z∑
z=1
{
1
2 tr
[
Ω−1W>z Σ−1z Wz
] }
+
δ
2 tr(Ω0Ω
−1)
s.t. Ω  0, tr(Ω) = 1
(12)
where Ω  0 means that the matrix Ω is positive semidenite.
Equation (12) has an analytical solution:
Ω =
(
1
2
∑Z
z=1 W
>
z Σ−1z Wz + δ2 Ω0
) 1
2
tr
[(
1
2
∑Z
z=1 W
>
z Σ−1z Wz + δ2 Ω0
) 1
2
] . (13)
Update Σz given others: With other parameters xed, the objec-
tive function w.r.t Σz becomes
arg min
Σz
1
2 tr
[
Ω−1W>z Σ−1z Wz
]
+
K
2 log |Σz |.
Similar to the case of updating Ω, the last term log |Σz | in Equation
(3) can be seen as a penalty on the complexity of Σz , and can be
replaced with a constraint tr(Σz ) = 1. en above Equation (3) can
be reformulated as:
arg min
Σz
tr
[
Ω−1W>z Σ−1z Wz
]
s.t. Σz  0, tr(Σz ) = 1. (14)
e Equation (14) has an analytical solution:
Σz =
(
WzΩ−1W>z
) 1
2
tr
[(
WzΩ−1W>z
) 1
2
] . (15)
4 EXPERIMENTS
In this section we present empirical evaluations to carefully vet
our model on patient level data extracted from a large real-world
electronic medical claims database.
4.1 Experimental Setup and Data
We conduct a retrospective cohort study using the MarketScan
Commercial Claims and Encounter (CCAE) database from Truven
Health1. e data on the patients are contributed by a selection
of large private employers’ health plans, as well as government
and public organizations. We use a dataset of de-identied patients
between the years 2011 and 2014. e patient cohort used in the
study consisted of T2DM patients selected based on the following
criteria:
I. e frequency ratio between Type 2 diabetes visits to Type
1 diabetes visits is larger than 0.5; AND
II-a. e patient has two (2) or more Type 2 diabetes labeled
events on dierent days; OR
II-b. e patient received insulin and/or antidiabetic medication.
We focus on the risk of developing complications in the two year
time window immediately following the initial T2DM diagnosis.
Guided by clinical experts and following the report from American
Diabetes Association [1], we identied 12 common complications
of T2DM. We selected patients with at least two years of observa-
tions before the initial T2DM diagnosis. Further, patients who were
under 19 years or age or over 64 years or age at the initial T2DM
diagnosis are removed. Table 2 shows the complications selected
in this study and the corresponding number of patients.
1hps://truvenhealth.com/
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Table 2: List of the T2DM complications and the number of subjects included in this study.
Complication Description Example ICD-9 codes # Subjects
Retinopathy (RET) Eye disease caused by damage to the blood vessels in the tissue at the back ofthe eye (retina)
25050, 25052, 24950, 24951,
36201-36207 7552
Neuropathy (NEU) Nerve damage most oen aecting the legs and feet 25060, 25062, 24960, 24961 11151
Nephropathy (NEP) Kidney disease or damage 25040, 25042, 24940, 24941 3969
Vascular Disease
(VAS)
Vascular diseases including peripheral vascular disease, cardiovascular disease,
and cerebrovascular diseases 25070, 25072, 24970, 24971 6735
Cellulitis (CEL) Serious bacterial skin infection 37313, 37531, 38010-38016 11148
Pyelonephritis (PYE) Inammation of the kidney, typically due to a bacterial infection 5900 - 5909 609
Osteomyelitis (OST) Inammation or infection of the bone and bone marrow; common in patientswith diabetic foot problems
73000-73007, 73009-73017,
73019-73027, 73029 909
Renal (REN) Renal failure 28521, 585, 5854-5856, 586,5845-5849 5172
Hyperosmolar state
(HHS)
One of two serious metabolic derangements characterized by hyperglycemia,
hyperosmolarity, and dehydration without signicant ketoacidosis 25020, 25022, 24920, 24921 1077
Ketoacidosis (KET) A complex disordered metabolic state characterized by hyperglycemia,ketoacidosis, and ketonuria 25010, 25012, 24910, 24911 1617
Sepsis (SEP) Immune response triggered by an infection that causes injury to the body’s owntissues and organs 0380-0389 2559
Shock (SHK) A critical condition brought on by a sudden drop in blood ow through the body 78550, 78551, 78552, 78559 777
We use following prediction variables:
• Patient demographics: age and gender.
• Diagnoses: historical medical conditions encoded as Inter-
national Classication of Disease (ICD) codes. ICD codes are
grouped according to their rst three digits and ICD codes
appearing in fewer than 200 patients are ltered out. is
results in 296 unique ICD features. Patients with less than 10
occurrences of ICD codes are removed.
• Medications: medications that were received before the ini-
tial T2DM diagnosis date. A total of 19 therapeutic classes
related to glucose control, cardiac related drugs, and antibi-
otics were selected.
is results in a total of 317 features.
4.2 Evaluation Protocol
Baselines. We compare the new TREFLES method with following
set of strong baselines:
• Single task learning (STL): For each task, we use a logistic
regression to model the risk of each complication indepen-
dently.
• Multi-task feature learning (MTFL) [3, 4]: MTFL assumes
that task association is captured through a subset of features
shared among tasks. It learns a few features common across
the tasks using group sparsity, i.e., the `1/`2-norm regular-
ization on W, which both couples the tasks and enforces
sparsity.
• Multi-task relationship learning (MTRL) [36]: MTRL as-
sumes that the task association is revealed in the structure of
the coecient matrix W, but it only considers the task corre-
lations in W neglecting the correlations between features.
• Feature and task relationship learning (FETR) [38]: FETR
learns the relationships both between tasks and between
features simultaneously. It can be seen a special case of our
model without feature grouping and correlated shrinkage.
Evaluation metrics. We evaluate the models using AUC (area un-
der the receiver operating characteristic curve), which is a standard
metric in predictive analytics.
Training and testing. We used 5-fold cross validation to report
results for each model. All the models are implemented with gradi-
ent descent optimization and we apply the Adam [19] method to
automatically adapt the step size during parameter estimation.
4.3 Incorporating Domain Knowledge
Grouping of features. We group ICD features according to the
domain knowledge encoded in the ICD ontologies. Specically, we
group ICD-9 codes together when they have a same parent node (3
digits) in the ICD-9 hierarchy.
Prior risk association Ω0. Note that our model can incorporate
prior knowledge on complication associations through Ω0. We
construct prior associations using the human disease network [16],
which provides the Phi-correlations between pairs of diseases. We
aggregate the Phi-correlations between pairs of ICD codes under
pairs of T2DM complications. is results in a Ω0 that represents
our prior knowledge about the correlations between the T2DM
complications in our study.
4.4 Results Comparison
Table 3 shows the AUCs between the proposed TREFLES model and
the baseline approaches on all 12 complication risk prediction tasks.
e average and standard deviation (in parenthesis) over the 5-
fold cross validation trials are reported. Our approach consistently
outperforms the baseline methods on all the 12 tasks. Figure 2 plots
the average AUCs and standard deviations across the 12 tasks for
the dierent methods.
MTL versus STL: We observe that all multi-task learning models
(MTFL, MTRL, FETR and TREFLES) consistently and signicantly
outperform the single task learning method. In particular, our TRE-
FLES model outperforms the single task learning method by 9.1%
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Table 3: Performance comparisons between the proposed TREFLES model and the baseline approaches for the 12 complica-
tions. e AUC average and standard deviation (in parenthesis) over the 5-fold cross validation trials are reported.
Method RET NEU NEP VAS CEL PYE OST REN HHS KET SEP SHK
STL 0.5397 0.5889 0.5905 0.6581 0.5983 0.6222 0.7574 0.7351 0.6186 0.6558 0.7611 0.7794(0.0108) (0.0092) (0.0096) (0.0096) (0.0049) (0.0263) (0.0468) (0.0110) (0.0323) (0.0240) (0.0152) (0.0410)
MTFL 0.5487 0.6034 0.6340 0.7059 0.6047 0.5604 0.8094 0.7801 0.6794 0.7011 0.7962 0.8316(0.0073) (0.0134) (0.0086) (0.0085) (0.0077) (0.0687) (0.0565) (0.0078) (0.0311) (0.0335) (0.0099) (0.0292)
MTRL 0.5643 0.6100 0.6456 0.7069 0.6283 0.6909 0.8480 0.7933 0.6990 0.7347 0.8182 0.8679(0.0087) (0.0103) (0.0099) (0.0105) (0.0046) (0.0633) (0.0534) (0.0073) (0.0187) (0.0348) (0.0178) (0.0209)
FETR 0.5815 0.6488 0.6336 0.7290 0.6589 0.6913 0.8610 0.8087 0.6878 0.7320 0.8298 0.8709(0.0178) (0.0063) (0.0126) (0.0137) (0.0067) (0.0474) (0.0506) (0.0163) (0.0304) (0.0416) (0.0140) (0.0262)
TREFLES 0.5985 0.6697 0.6655 0.7478 0.6793 0.7194 0.8828 0.8316 0.7229 0.7626 0.8425 0.8784(0.0150) (0.0075) (0.0130) (0.0091) (0.0074) (0.0422) (0.0571) (0.0130) (0.0242) (0.0341) (0.0165) (0.0247)
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Figure 2: Performance comparisons between the proposed
TREFLES model and the baseline approaches in terms of
AUC (averaged over all 12 tasks).
in AUC on average. is conrms our assumption that directly
modeling complications as independent of one another can lead
to suboptimal models. Note that the dierent complications are
manifestations of a common underlying condition–hyperglycemia,
so their risks should be related. By simultaneously modeling multi-
ple complications, MTL can capture and leverage the associations
between complications using a shared representation. As a result,
MTL models can signicantly outperform STL models in risk pre-
diction of T2DM complications.
TREFLES model versus baseline MTL models: As shown in
Figure 2, our TREFLES model outperforms all baseline MTL models.
TREFLES (AUC 0.7501 ± 0.0091) is beer than the best baseline
model FETR (AUC 0.7278 ± 0.0094) by 2.2% in AUC. We also ob-
serve that the task relationship learning based method MTRL (AUC
0.7173 ± 0.0072) is more favorable than the feature relationship
learning based method MTFL (AUC 0.6879 ± 0.0128). FETR outper-
forms MTRL because it simultaneously learns the relationships both
between tasks and between features. TREFLES not only captures
the relationships between tasks and between features, it also iden-
ties the common contributing risk factors through the correlated
coecient shrinkage mechanism and incorporates domain knowl-
edge through carefully constructed priors. As a result, TREFLES
can signicantly improve upon FETR.
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Figure 3: Heatmap and dendrogram of the hierarchical clus-
tering of the correlation matrix learned by TREFLES.
4.5 Learned Risk Associations
In this section we discuss the estimated risk association matrix
Ωˆ from our TREFLES model. Matrix Ωˆ represents the relatedness
between complications learned from data. We rst transfer the
covariance matrix Ωˆ to its correlation matrix Rˆ, whose elements
have a ranges from −1 to 1. We observe that all the elements in
the correlation matrix Rˆ learned by TREFLES have positive values.
is is because all the complications are manifestations of a com-
mon underlying condition–hyperglycemia and they are positively
correlated. en we perform a hierarchical clustering on Rˆ. Figure
3 shows the heatmap and the dendrogram of the hierarchical clus-
tering results. Darker colors indicate higher correlation. We can
observe clusters between the risk associations of the 12 complica-
tions. In particular, CEL, NEU, VAS, OST, NEP and RET form one
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cluster while the remaining complications of KET, HHS, PYE, SEP,
REN and SHK form a second cluster.
e clusters are clinically meaningful. e rst cluster of CEL,
NEU, VAS, OST, NEP and RET represents the local complications
caused by long standing or mismanaged diabetes, and the second
cluster of KET, HHS, PYE, SEP, REN and SHK represents complica-
tions involving multiple sites or systemic complications. Cluster
2 indicates more severe pathophysiologic manifestations of the
disease than the cluster 1.
4.6 Identied Risk Factors
Table 4 shows the top-5 risk factors/predictors (according to their
coecients) for each diabetic complication identied by our model.
Most of the risk factors identied by our model are known to be
clinically associated with the corresponding diabetic complications
(indicated by *). For example, the medical condition of “Disor-
ders of uid, electrolyte, and acid-base balance”, which consistently
appears in the top listing for all the diabetic complications, is indica-
tive of many acid-based and electrolyte disorders that may be due
to complications of T2DM and the medications diabetic patients re-
ceive. Age is another major known risk factor for retinopathy, neu-
ropathy, nephropathy and vascular disease including cardiovascular
disease and the proposed method correctly identies these associa-
tions. e underlying mechanism of age as a risk factor could be
due to the fact that older adults tend to have long-standing diabetes,
and consequently have associated microvascular and macrovascu-
lar complications. Insulin treatment is identied as a risk factor
for retinopathy, nephropathy, and cellulitis but not for the other
complications.
5 RELATEDWORK
From an applications perspective, our work falls into the cate-
gory of studies that apply predictive analytics and use longitu-
dinal patient records to improve the practice of healthcare man-
agement. Building predictive models from EHRs and electronic
medical claims data have aracted signicant aention from both
academia and industry, and have been applied to disease onset
prediction [11, 12, 18, 21, 25], disease progression [30], patient
stratication [10, 31], hospital readmission prediction [5, 17], and
mortality prediction [22, 28]. More recently, there have been some
work focusing on diabetes. Razavian et al. [25] show that claims
data can be leveraged to predict T2DM onset. Oh et al. [23] ap-
plied EHRs to capture the trajectories of T2DM patients and found
that dierent trajectories can lead to dierent risk paerns. Liu
et al. [20] applied survival analysis to predict the onset of T2DM
complications. Yadav et al. [34] presents a comprehensive survey
on EHR data mining. Dierent from previous studies, this paper
presents a comprehensive study to investigate the risk prediction
and proling of T2DM complications from patient medical records
for diabetes care through a novel multi-task learning model.
Our work is also related to multi-task learning (MTL) [6], which
aims to jointly learn multiple tasks using a shared representation
so that knowledge obtained from one task can help other tasks.
Recently, MTL models have been widely used in the healthcare
domain [20, 22, 27, 32, 39]. Feature relationship learning based
approaches (known as MTFL) [3, 4] and task relationship learning
based approaches (known as MTRL) [36] are the two most widely
used MTL strategies [35]. MTFL assumes that task association is
released through a subset of features shared among tasks. MTRL
assumes that the task association is revealed in the structure of
the coecient matrix. Most similar to our approach is the feature
and task relationship learning (FETR) method recently proposed
by Zhao et al. [38]. Similar to FETR, our proposed TREFLES model
is a generalization of both MTRL and MTFL, and simultaneously
learns the relationships both between tasks and between features.
In healthcare analytics, associations between features are usually
not ignorable. Dierent from FETR, TREFLES captures more ne-
grained feature relationships by grouping features into groups ac-
cording to domain knowledge. Furthermore, TREFLES is able to
capture the correlated coecient shrinkage among tasks through
a novel correlated Horseshoe prior. As shown in our study, TRE-
FLES is favorable for healthcare applications where we not only
obtain beer prediction performances, but also derive clinically
meaningful insights about the relationships among the dierent
complications and among the dierent risk factors.
6 CONCLUSION
In this paper, we provided a systematic study on risk proling by
simultaneously modeling multiple complications in chronic disease
care using T2DM as a case study. We proposed a novel multi-task
learning model, TREFLES, that jointly captures relationships be-
tween risks, risk factors, and risk factor selection learned from
the data with the ability to incorporate domain knowledge as pri-
ors. TREFLES is favorable for healthcare applications because in
additional to improved prediction performance, clinically meaning-
ful insights about the relationships among dierent complications
and risk factors can also be identied. Extensive experiments on
a T2DM patient dataset extracted from a large electronic medical
claims database validated the improved prediction performance of
TREFLES over current state of the art methods. Also the risk associ-
ations learned as well as the risk factors identied by TREFLES lead
to meaningful insights that were consistent with clinical ndings.
ere are a number of interesting future research directions.
First, dierent complications could correspond to dierent severi-
ties of diabetes and we can use this knowledge to impose additional
constraints on the risk correlations to potentially improve perfor-
mance. Second, the coecient shrinkage strategy can be extended
to incorporate domain knowledge about the risk factors to poten-
tially improve interpretability. Finally, we are also interested in
applying our model to other chronic disease conditions with multi-
ple complications or comorbidities which might benet from the
proposed modeling innovations proposed here.
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